Pazocam 400mg Tablet
Marketer
Medicamen Biotech Ltd
Salt Composition
Pazopanib (400mg)
Overview Pazocam 400mg Tablet
Oncaspar 400mg tablets, a protein kinase inhibitor, are indicated for kidney cancer and soft tissue sarcoma. Administer this medication on an empty stomach, consistently at the same time daily for optimal efficacy. Dosage and frequency are determined by your physician based on your condition and may be adjusted. Strictly adhere to your doctor's prescribed regimen; incorrect usage or overdose can lead to severe adverse effects. Therapeutic benefits may not be immediately apparent, potentially taking weeks or months; discontinue only under medical supervision. Common side effects include elevated blood pressure and diarrhea. Regular blood pressure monitoring is often recommended. Manage diarrhea by increasing fluid intake or consulting your physician if it persists. This medication can lower blood cell counts, raising infection risk; report fever, flu-like symptoms, or shortness of breath immediately. Prior to commencing treatment, disclose any pre-existing heart, liver, or kidney conditions, and all current medications, especially those for infections. Significant drug interactions are possible; inform your healthcare provider of all medications. This medicine is contraindicated during pregnancy and breastfeeding; reliable contraception for both partners is essential throughout treatment.
Uses of Pazocam 400mg Tablet
Renal cell carcinoma/Malignant soft tissue tumor
Major Benefits of Pazocam 400mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 400mg Pazocam tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
Common Side effects of Pazocam 400mg Tablet:
- Headache
- Nausea
- Vomiting
- Musculoskeletal (bone, muscle or joint) pain
- Fatigue
- Change in color of hair
- Diarrhea
- High blood pressure
- Decreased appetite
- Weight loss
- Taste change
- Abnormal skin pigmentation
- Hair discoloration
- Tumor pain
- Breathlessness
How to use Pazocam 400mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the 400mg Pazocam tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.
How Pazocam 400mg Tablet works:
Pazocam 400mg tablets are an anticancer agent. Their mechanism involves targeted disruption of tyrosine kinase enzyme receptors, thereby curbing cancerous cell multiplication. Additionally, the medication inhibits angiogenesis, restricting tumor blood supply and further limiting growth. This dual action underlies its anti-cancer efficacy.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Pazocam 400mg Tablets may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Pazocam 400mg tablets during pregnancy poses a confirmed risk to the fetus. A physician might exceptionally prescribe it in critical circumstances where the potential advantages outweigh the inherent dangers. Physician consultation is essential.
Breast feedingUNSAFE
Lactation and the use of 400mg Pazocam tablets are incompatible. Evidence indicates potential infant harm from this medication.
DrivingUNSAFE
Taking a 400mg Pazocam tablet might cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can safely use Pazocam 400mg tablets without requiring any dosage modification.
LiverCAUTION
Patients with liver impairment should use Pazocam 400mg tablets cautiously, potentially requiring dosage modification under medical supervision. Pazocam 400mg tablets are contraindicated for individuals with moderate to severe hepatic dysfunction.
What if you forget to take Pazocam 400mg Tablet :
NA
Facts to Know About Pazocam 400mg Tablet
Label | Value |
---|---|
Chemical Type | Diarylalkylamines |
Developing Habits | No. |
Treatment Category | Cancer Medications |
Actions | Kinase inhibitors targeting tyrosine |